Keywords
How to Cite
Abstract
Radiation-induced oral mucositis (RIOM) is aimed at evaluating the expression of NF-κβ, IL-1α, IL-6, IL-8 and TNF-α in patients with RIOM so as to validate their role in the pathobiology of the disease. Blood samples were collected and serum of 45 patients isolated with clinical signs and symptoms of mucositis and 10 healthy controls were also included in the study. The expression level of NF-κβ, IL-1α, IL-6, IL-8, TNF-α was investigated using ELISA. Mann Whitney U test was applied to find the significance of the expression of these markers in RIOM patients as compared to normal healthy controls and significant expression (P< 0.05) for NF-κβ, IL-6, TNF-α and non-significant expression (P > 0.05) IL-1α and IL-8 was found. No significant change in the expression level of the cytokines was observed for patients undergoing chemotherapy and radiation therapy as well as those receiving only the radiation therapy as a part of their treatment. We have also found less expression in grade 1 of mucositis as compared to grade 4. Pro- inflammatory cytokines indeed play a vital role in the pathogenesis as well as progression of RIOM.
References
Rizvi MM, Alam MS, Ali A, Mehdi SJ, Batra S, Mandal AK. Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population. J Cancer Res Clin Oncol. 2011 Aug;137(8):1255-62. doi: 10.1007/s00432-011-0994-0.
Rizvi MM, Ali A, Mehdi SJ, Saluja SS, Mishra PK. Association of
Cytokine Expression in RIOM Patients
Braz J Oral Sci. 15(4):280-286
Cytokine Expression in RIOM Patients
epigenetic alteration in PTEN gene with colorectal cancer progression among Indian population. Int J Colorectal Dis. 2013 Feb;28(2):283-4. doi: 10.1007/s00384-012-1482-y.
Dirix P, Nuyts S, Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer. 2006 Dec;107(1):2525-34.
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al., Perspectives on cancer therapy-induced mucosal injury: pathogen¬esis, measurement, epidemiology, and consequences for patients. Cancer. 2004 May;100(9 Suppl):1995-2025.
Peterson DE, Bensadoun RJ, Roila F; ESMO Guidelines Working Group. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol. 2011 Sep;22 Suppl 6:vi78-84. doi: 10.1093/annonc/mdr391. Erratum in: Ann Oncol. 2012 Mar;23(3):810.
Peterson DE. New Strategies for Management of Oral Mucositis in Cancer Patients. J Support Oncol. 2006 Feb;4(2 Suppl 1):9-13.
Pico JL, Avila-Garavito A, Naccache P. Mucositis: its occurrence, consequences, and treatment in the oncology setting. Oncologist. 1998;3(6):446-51.
Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al., Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol. 2003 Mar;66(3):253-62.
Silverman S Jr. Diagnosis and management of oral mucositis. J Support Oncol. 2007 Feb;5(2 Suppl 1):13-21.
Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST; Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004 May 1;100(9 Suppl):2026-46.
Sonis ST, O’Donnell KE, Popat R, Bragdon C, Phelan S, Cocks D, et al. The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis. Oral Oncol. 2004 Feb;40(2):170-6.
Dorr W, Hamilton CS, Boyd T, Reed B, Denham JW. Radiation-induced changes in cellularity and proliferation in human oral mucosa. Int J Radiat Oncol Biol Phys. 2002 Mar;52(4):911-7.
Sonis ST. The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit Rev Oral Biol Med. 2002;13(5):380-9.
Sonis ST. Pathobiology of Oral Mucositis: novel insights and opportunities. J Support Oncol. 2007 Oct;5(9 Suppl 4):3-11.
Yeoh ASJ, Bowen JM, Gibson RJ, Keefe DM. Nuclear factor κB (NFκB) AND cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. Int. J. Radiation Oncology Biol. Phys. 2005 Dec;63(5):1295-303.
Satheesh Kumar PS. Radiation Mucositis. In: Racz GB, Noe CE, editors. Pain Management - Current Issues and Opinions. InTech. Chapter 22. ISBN: 2012.978-953-307-813-7. Available from: https://www.intechopen. com/books/pain-management-current-issues-and-opinions/radiationmucositis.
Logan RM, Gibson RJ, Sonis ST, Keefe DM. Nuclear factor-κappaB (NFkappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol. 2007 Apr;43(4):395-401.
Sultani M, Stringer AM, Bowen JM, Gibson RJ. Anti-Inflammatory Cytokines: Important Immunoregulatory Factors Contributing to Chemotherapy-Induced Gastrointestinal Mucositis. Chemother Res Pract. 2012;2012:490804. doi: 10.1155/2012/490804.
Yeoh A, Gibson R, Yeoh E, Bowen J, Stringer A, Giam K, et al. Radiation therapy-induced mucositis: relationships between fractionated radiation, NF-κB, COX-1, and COX-2. Cancer Treat Rev. 2006 Dec;32(8):645-51.
Brach MA, Hass R, Sherman ML, Gunji H, Weichselbaum R, Kufe D. Ionizing radiation induces expression and binding activity of the nuclear factor, kappa B. J Clin Invest. 1991 Aug;88(2):691-5.
Lee SJ, Dimtchev A, Lavin MF, Dritschilo A, Jung M. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene. 1998 Oct;17(14):1821-6.
Ong ZY, Gibson J, Bowen JM, Stringer AM, DarbyJM, Logan RM, et al. Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis. Radiat Oncol. 2010 Mar;5:22. doi: 10.1186/1748-717X-5-22.
Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998 Jan;34(1):39-43.
Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther. 2008 Jul;7(7):113945.
Kelly CP, Keates S, Siegenberg D, Linevsky JK, Pothoulakis C, Brady HR. IL-8 secretion and neutrophil activation by HT-29 colonic epithelial cells. Am J Physiol. 1994 Dec;267(6 Pt 1):991-7.
Campbell BJ, Yu LG, Rhodes JM. Altered glycosylation in inflammatory bowel disease: A possible role in cancer development. Glycoconj. 2001 Nov-Dec;18(11-12):851-8.
Ikeda Y, Ito M, Matsuu M, Shichijo K, Fukuda E, Nakayama T et al., Expression of ICAM-1 and acute inflammatory cell infiltration in the early phase of radiation colitis in rats. J Radiat Res. 2000 Sep;41(3):279-91.
Duncan M, Grant G. Oral and intestinal mu¬cositis—causes and possible treatments. Aliment Pharmacol Ther. 2003 Nov;18(9):853-74.
Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis. 2006 May;12(3):22941.
Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DM. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol. 2008 Jun;62(1):33-41.
Ikebe T, Yamasakia K, Takamunea Y, Nakayamaa H, Shinohara M. Reduced expression of nuclear factor kB in oral mucosa undergoing preoperative chemoradiotherapy. Oral Science International. 2012 Nov;992):33-7. doi:10.1016/S1348-8643(12)00008-0.
Khaw A, Logan R, Keefe D, Bartold M. Radiation-induced oral mucositis and periodontitis – proposal for an inter-relationship. 2014 Apr;20(3):e7-18. doi: 10.1111/odi.12199.
Lima V, Brito GA, Cunha FQ, Rebouças CG, Falcão BA, Augusto RF, et al., Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters. Eur J Oral Sci. 2005 Jun;113(3):210-7.
Ferra C, de Sanjose S, Lastra CF, Martí F, Mariño EL, Sureda A, et al. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications. Bone Marrow Transplant. 1997 Dec;20(12):1075-80.
Yeoh ASJ, Gibson RJ, Yeoh E, Bowen JM, Stringer AM, Giam KA, et al. A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-KB, COX-1, and COX-2. Mol Cancer Ther. 2007 Aug;6(8):2319-27.
Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, et al. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev. 2007 Aug;33(5):448-60.
Gibson RJ, Keefe DM, Thompson FM, Clarke JM, Goland GJ, Cummins AG. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breastcancer in rats. Dig Dis Sci. 2002 Dec;47(12):2751-7.
Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DM. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol. 2003 Sep;18(9):1095-100.
Gibson RJ, Bowen JM, Cummins AG, Keefe DM. Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the rat. Clin Exp Med. 2005 Mar;4(4):188-95.
Soares PMG, Mota J, Souza EP, Justino PF, Franco AX, Cunha FQ, et al. Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4. Cytokine. 2013 Jan;61(1):46-9. doi: 10.1016/j.cyto.2012.10.003.
Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother Pharmacol. 2009 Jan;63(2):239-51. doi: 10.1007/ s00280-008-0732-8.
The Brazilian Journal of Oral Sciences uses the Creative Commons license (CC), thus preserving the integrity of the articles in an open access environment.
Downloads
